StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) operating KPIs

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)

Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%

AbbVie long-term debt and finance lease obligations ($M) ($M)

Form 10-Q / 10-K

QuarterlyAnnual
Latest, FY2025
58,941
Period ended Dec 31, 2025
Change on a year earlier
-2.3%
60,340 in FY2024
History
14 years
Since FY2012
Sources
14
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedLong-term debt and finance lease obligations ($M) ($M)Year on yearSource
FY2025Dec 31, 202558,941-2.3%Form 10-K (filed 2026-02-20) ↗
FY2024Dec 31, 202460,340+15.6%Form 10-K (filed 2025-02-14) ↗
FY2023Dec 31, 202352,194-11.7%Form 10-K (filed 2024-02-20) ↗
FY2022Dec 31, 202259,135-7.9%Form 10-K (filed 2023-02-17) ↗
FY2021Dec 31, 202164,189-17.2%Form 10-K (filed 2022-02-18) ↗
FY2020Dec 31, 202077,554+23.2%Form 10-K (filed 2021-02-19) ↗
FY2019Dec 31, 201962,975+79.9%Form 10-K (filed 2020-02-21) ↗
FY2018Dec 31, 201835,002+13.1%Form 10-K (filed 2019-02-27) ↗
FY2017Dec 31, 201730,953-15.1%Form 10-K (filed 2018-02-16) ↗
FY2016Dec 31, 201636,440+24.6%Form 10-K (filed 2017-02-17) ↗
FY2015Dec 31, 201529,240+177.5%Form 10-K (filed 2016-02-19) ↗
FY2014Dec 31, 201410,538-26.3%Form 10-Q (filed 2015-08-07) ↗
FY2013Dec 31, 201314,292-2.3%Form 10-K (filed 2014-02-21) ↗
FY2012Dec 31, 201214,630–Form 10-Q (filed 2013-05-08) ↗

Cite this data

StockData. (2026). AbbVie Long-term debt and finance lease obligations ($M) ($M), annual FY2012–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/fs_ltd

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.